Figure 2From: Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome Kaplan-Meier curves showing the probability of overall survival for patients with gastric cancer according to SOX2 expression (A) and according to the molecular phenotypes SOX2 - /CDX2 + and SOX2 + /CDX2 - (B). Back to article page